Healthcare -
Biotechnology - NASDAQ - US
$ 0.4
-42.8 %
$ 145 M
Market Cap
-0.54
P/E
LXRX - CAPITAL EXPENDITURES
Capital Expenditures LXRX - Lexicon Pharmaceuticals, Inc.
-470 K
LAST VALUE
37.96%
2 YEAR CAGR
-37.68%
5 YEAR CAGR
12.17%
10 YEAR CAGR